FUROXONE Drug Patent Profile
✉ Email this page to a colleague
When do Furoxone patents expire, and what generic alternatives are available?
Furoxone is a drug marketed by Shire and is included in two NDAs.
The generic ingredient in FUROXONE is furazolidone. There are three drug master file entries for this compound. Additional details are available on the furazolidone profile page.
Summary for FUROXONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 102 |
Patent Applications: | 2,522 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FUROXONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FUROXONE
US Patents and Regulatory Information for FUROXONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | FUROXONE | furazolidone | SUSPENSION;ORAL | 011323-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shire | FUROXONE | furazolidone | TABLET;ORAL | 011270-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |